According to the Chinese Society of Clinical Oncology Breast Cancer Guidelines, neoadjuvant treatment for breast cancer was performed, and the TAC regimen was adopted, with doxorubicin hydrochloride liposome injection liquid 40 mg, cyclophosphamide 800 mg, and albumin paclitaxel 400 mg on static drip. Here, ALB is linked to breast cancer.